Clin2
NCT07811063Possibly a fitNot yet recruiting

Testing a new tablet in healthy adults

Healthy Volunteers

This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
10 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be a generally healthy adult between 18 and 55 years old.
  • Your weight and height must be within a specific range (BMI 18–32).
  • You cannot have a history of seizures or significant head injury.
  • You must have no significant heart problems, like an abnormal heart rhythm.
  • You must be a nonsmoker or smoke very little (fewer than 10 cigarettes a week).
  • If you can become pregnant, you must agree to use reliable birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07300189Recruiting· Phase 1
Testing TLC-1180 in healthy volunteers

This study tests a new medicine called TLC-1180 in healthy volunteers to see how it works in the body. It's a first step to find a safe dose before studying it in people with illness.

Auckland
NCT07777549Not yet recruiting· Phase 2
Testing a new medicine for ringing in the ears

This study tests an investigational drug called TRTL-913 in healthy volunteers first, then in adults with constant ringing in the ears (tinnitus). The goal is to see if it is safe and if it reduces tinnitus symptoms.

Auckland
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.